Position
Treasurer
Company
Arvinas
New HavenBiotechnologyHealth CareTherapeuticsresearchDescription
Arvinas, Inc announced the appointment of Andrew Saik as the Chief Financial Officer and Treasurer. Mr Saik brings over 20 years of biopharma finance experience to the company, having previously served in leadership roles at Intercept Pharmaceuticals, Inc, Vyne Therapeutics Inc, PDS Biotechnology, Corp, Vertice Pharma, LLC, and Auxilium Pharmaceuticals, Inc.
Quick answer
Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer (June 24, 2024). Arvinas is based in New Haven, Connecticut, United States.
- Who is the new Treasurer at Arvinas?
- Arvinas named Andrew Saik Treasurer, announced June 24, 2024.
- What did Arvinas announce on June 24, 2024?
- Arvinas, Inc announced the appointment of Andrew Saik as the Chief Financial Officer and Treasurer.
- What does Arvinas do?
- Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of...
- Where is Arvinas based?
- Arvinas is based in New Haven, Connecticut, United States.
- Which similar companies made leadership changes around the same time?
- Brainstorm Cell Therapeutics (June 20, 2024), Avalo Therapeutics (June 24, 2024), MaaT Pharma (June 24, 2024) and MBX Biosciences, Inc. (June 25, 2024) also announced leadership changes within 45 days of Arvinas.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and research
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- BrainStorm Cell Therapeutics Inc. Appoints Hartoun Hartounian Ph.D. as EVP and COO (June 20, 2024)
- Avalo Therapeutics Appoints Paul Varki as Chief Legal Officer (June 24, 2024)
- MaaT Pharma Appoints Gianfranco Pittari, M.D., Ph.D., as Chief Medical Officer (June 24, 2024)
- MBX Biosciences Appoints Salomon (Sam) Azoulay, M.D, as Chief Medical Officer (June 25, 2024)
- Actym Therapeutics Appoints Mary J. Janatpour as Chief Scientific Officer and Shouryadeep Srivastava as Senior Vice President of Clinical Development (June 25, 2024)
- Immunome Appoints Phil Tsai, PhD, as Chief Technical Officer (June 27, 2024)
Who to call at Arvinas, and when
A new leader at Arvinas brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Arvinas raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Arvinas, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Arvinas. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Arvinas changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Arvinas changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.